Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment
Authors:
- Konstantinos G. LasithiotakisKLKonstantinos G. Lasithiotakis
- Ioannis E. PetrakisIPIoannis E. Petrakis
- Claus GarbeClaus Garbe
- 1 June 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 20 (3) , 163-170
Abstract
The incidence and mortality of cutaneous melanoma (CM) has increased over the last decades in fair-skinned populations. Incidence and mortality, as well as rates of increase, have been significantly higher in elderly people compared with younger age groups. Lower survival rates from CM among elderly are mainly the result of late diagnosis of tumors with dismal prognostic features. Expansion of current preventive strategies to include older age groups is therefore warranted. Despite differences in clinical presentation and pathological characteristics of CM in the elderly, there is no evidence that primary surgical treatment should differ from that proposed generally for melanoma. However, the rate of positive sentinel node dissection decreases with age, even though overall survival is shorter in older patients, a paradox that remains to be explained. The use of adjuvant treatment with interferon-alpha in elderly patients requires careful discussion of the risks and benefits, especially when serious illness coexists. For metastatic melanoma, complete metastasectomy is the only treatment associated with benefit for overall survival. However, careful selection of surgical oncogeriatric candidates is necessary, probably with the use of tools to provide a comprehensive geriatric assessment, to identify patients more likely to benefit from this treatment. In the absence of any effective systemic treatment for disseminated CM, new therapeutic agents are urgently needed. Practical means to improve accrual of older patients in clinical trials are necessary to provide better evidence for their treatment.Keywords
This publication has 63 references indexed in Scilit:
- Melanoma incidence and mortality in Scotland 1979–2003British Journal of Cancer, 2007
- The incidence and mortality of cutaneous melanoma in southern GermanyCancer, 2006
- Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003British Journal of Cancer, 2006
- Invasive cutaneous malignant melanoma in Sweden, 1990–1999Cancer, 2004
- Nodular Type and Older Age as the Most Significant Associations of Thick Melanoma in Victoria, AustraliaArchives of Dermatology, 2002
- Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United StatesJNCI: Journal of the National Cancer Institute, 2001
- Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996International Journal of Cancer, 2001
- Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985–1992European Journal of Epidemiology, 2001
- Update on the incidence and mortality from melanoma in the United StatesJournal of the American Academy of Dermatology, 1999
- The National Cancer Data Base report on cutaneous and noncutaneous melanomaCancer, 1998